Clinical trial for Chronic Pain
Official title Reboot Pain (tDCS)
ClinicalTrials.gov ID: NCT07411859
What this study is testing
- What it's testing
- The study wants to find out whether transcranial direct current stimulation can reduce chronic pain, measured with a pain questionnaire.
- Who it's for
- Veterans who are in the Emory Healthcare Veterans Program Accelerated Behavioral Health Program and have chronic pain.
- What's involved
- Participants will receive tDCS, a gentle electrical current applied to the scalp, and will complete pain rating scales.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Male or Female, 18-89 years old
- Treated on site for ABHP
- Willing to self-administer tDCS and complete the measures
- PEG pain intensity of 4 or more for most of the day at least 3 days per week
- Have an established PCP (Primary Care Provider) or pain management provider
You likely can't join if
- Implanted pacemaker
- Seizure Disorder
- Pregnancy, if applicable
- Balance Problems
- Difficulty walking
- Bladder incontinence
See the full eligibility criteria
- Male or Female, 18-89 years old
- Treated on site for ABHP
- Willing to self-administer tDCS and complete the measures
- PEG pain intensity of 4 or more for most of the day at least 3 days per week
- Have an established PCP (Primary Care Provider) or pain management provider
- Implanted pacemaker
- Seizure Disorder
- Pregnancy, if applicable
- Balance Problems
- Difficulty walking
- Bladder incontinence
- Bowel incontinence
- Numbness
- Tingling
- Weakness
- Medical contraindications
- Current use of sodium channel blockers
- Lidocaine (OTC/transdermal delivery is ok)
- Mexiletine
- Amitriptyline; other tricyclic antidepressants
- Anti-epileptic medications: phenytoin, carbamazepine, lamotrigine, oxcarbazepine, rufinamide, lacosamide and eslicarbazepine acetate
- Current use of calcium channel blockers
- Current use of N-Methyl-D-aspartate receptor antagonists
- Ketamine
- Dextromethorphan
- Felbamate
- History of brain surgery
- History of brain tumor
- History of seizure disorder
- History of stroke
- Intracranial metal implantation
- Adults unable to consent
- Individuals who are not yet adults
- Prisoners
- Non-English speaking
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.